Jessica M. Fogel, Ph.D. - Publications

Affiliations: 
2012 Johns Hopkins University, Baltimore, MD 
Area:
HIV

45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Fogel JM, Persaud D, Piwowar-Manning E, Richardson P, Szewczyk J, Marzinke MA, Wang Z, Guo X, McCauley M, Farrior J, Tran HV, Ungsedhapand C, Mathew CA, Mpendo J, Rinehart AR, et al. HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084. Aids Research and Human Retroviruses. PMID 39466048 DOI: 10.1089/aid.2024.0049  0.78
2024 Landovitz RJ, Delany-Moretlwe S, Fogel JM, Eshleman SH, Marzinke MA, Piwowar-Manning E, Richardson P, Halvas EK, Mellors JW, Persaud D, Kofron R, McCauley M, Rose S, Rinehart AR, Rooney JF, et al. Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis. The New England Journal of Medicine. PMID 39046350 DOI: 10.1056/NEJMc2402088  0.762
2024 Fogel JM, Piwowar-Manning E, Moser A, Hill T, Ahmed S, Cummings V, Mostafa HH, Wang Z, Jennings A, Gallardo-Cartagena JA, Figueroa MI, St Clair M, Rinehart AR, Adeyeye A, Rooney JF, et al. Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis. Microbiology Spectrum. e0030724. PMID 38980027 DOI: 10.1128/spectrum.00307-24  0.79
2024 Moore HP, Palumbo PJ, Notarte KI, Fogel JM, Cummings V, Gamble T, Del Rio C, Batey DS, Mayer KH, Farley JE, Remien RH, Beyrer C, Hudelson SE, Eshleman SH. Performance of the Applied Biosystems HIV-1 Genotyping Kit with Integrase. Journal of Clinical Microbiology. e0013624. PMID 38727213 DOI: 10.1128/jcm.00136-24  0.758
2024 Goodman-Meza D, Shoptaw S, Hanscom B, Smith LR, Andrew P, Kuo I, Lake JE, Metzger D, Morrison EAB, Cummings M, Fogel JM, Richardson P, Harris J, Heitner J, Stansfield S, et al. Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study). Trials. 25: 124. PMID 38360750 DOI: 10.1186/s13063-023-07899-5  0.522
2023 Marzinke MA, Fogel JM, Wang Z, Piwowar-Manning E, Kofron R, Moser A, Bhandari P, Gollings R, Bushman LR, Weng L, Halvas EK, Mellors J, Anderson PL, Persaud D, Hendrix CW, et al. Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083. Antimicrobial Agents and Chemotherapy. e0005323. PMID 36995219 DOI: 10.1128/aac.00053-23  0.789
2022 Fogel JM, Zewdie K, Clarke WA, Piwowar-Manning E, Breaud A, Moore A, Kosloff B, Shanaube K, van Zyl G, Scheepers M, Floyd S, Bock P, Ayles H, Fidler S, Hayes R, et al. Antiretroviral Drug Detection in a Community-Randomized Trial of Universal HIV Testing and Treatment: HPTN 071 (PopART). Open Forum Infectious Diseases. 9: ofac576. PMID 36447611 DOI: 10.1093/ofid/ofac576  0.774
2022 Eshleman SH, Fogel JM, Halvas EK, Piwowar-Manning E, Marzinke MA, Kofron R, Wang Z, Mellors J, McCauley M, Rinehart AR, Clair MS, Adeyeye A, Hinojosa JC, Cabello R, Middelkoop K, et al. HIV RNA screening reduces integrase strand transfer inhibitor resistance risk in persons receiving long-acting cabotegravir for HIV prevention. The Journal of Infectious Diseases. PMID 36240386 DOI: 10.1093/infdis/jiac415  0.795
2022 Fogel JM, Wilson EA, Piwowar-Manning E, Breaud A, Clarke W, Petropoulos C, Moore A, Fraser C, Kosloff B, Shanaube K, van Zyl G, Scheepers M, Floyd S, Bock P, Ayles H, et al. HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART). Journal of the International Aids Society. 25: e25941. PMID 35775502 DOI: 10.1002/jia2.25941  0.792
2022 Eshleman SH, Fogel JM, Piwowar-Manning E, Chau G, Cummings V, Agyei Y, Richardson P, Sullivan P, Haines CD, Bushman LR, Petropoulos C, Persaud D, Kofron R, Hendrix CW, Anderson PL, et al. Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084. The Journal of Infectious Diseases. PMID 35301540 DOI: 10.1093/infdis/jiab576  0.807
2021 Soni N, Giguère K, Boily MC, Fogel JM, Maheu-Giroux M, Dimitrov D, Eshleman SH, Mitchell KM. Under-Reporting of Known HIV-Positive Status Among People Living with HIV: A Systematic Review and Meta-analysis. Aids and Behavior. PMID 34046763 DOI: 10.1007/s10461-021-03310-z  0.705
2021 Marzinke MA, Grinsztejn B, Fogel JM, Piwowar-Manning E, Li M, Weng L, McCauley M, Cummings V, Ahmed S, Haines CD, Bushman LR, Petropoulos C, Persaud D, Adeyeye A, Kofron R, et al. Characterization of HIV infection in cisgender men and transgender women who have sex with men receiving injectable cabotegravir for HIV prevention: HPTN 083. The Journal of Infectious Diseases. PMID 33740057 DOI: 10.1093/infdis/jiab152  0.79
2020 Grant-McAuley W, Fogel JM, Galai N, Clarke W, Breaud A, Marzinke MA, Mbwambo J, Likindikoki S, Aboud S, Donastorg Y, Perez M, Barrington C, Davis W, Kerrigan D, Eshleman SH. Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic. Plos One. 15: e0240890. PMID 33119663 DOI: 10.1371/journal.pone.0240890  0.815
2020 Fogel JM, Bonsall D, Cummings V, Bowden R, Golubchik T, de Cesare M, Wilson EA, Gamble T, Del Rio C, Batey DS, Mayer KH, Farley JE, Hughes JP, Remien RH, Beyrer C, et al. Performance of a high-throughput next-generation sequencing method for analysis of HIV drug resistance and viral load. The Journal of Antimicrobial Chemotherapy. PMID 32772080 DOI: 10.1093/Jac/Dkaa352  0.765
2020 Eshleman SH, Piwowar-Manning E, Wilson EA, Lennon D, Fogel JM, Agyei Y, Sullivan PA, Weng L, Moore A, Laeyendecker O, Kosloff B, Bwalya J, Maarman G, van Deventer A, Floyd S, et al. Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART). Journal of the International Aids Society. 23: e25452. PMID 32072743 DOI: 10.1002/Jia2.25452  0.828
2019 Fogel JM, Sivay MV, Cummings V, Wilson EA, Hart S, Gamble T, Laeyendecker O, Fernandez RE, Del Rio C, Batey DS, Mayer KH, Farley JE, McKinstry L, Hughes JP, Remien RH, et al. HIV drug resistance in a cohort of HIV-infected men who have sex with men in the United States. Aids (London, England). PMID 31634196 DOI: 10.1097/Qad.0000000000002394  0.818
2019 Palumbo PJ, Zhang Y, Fogel JM, Guo X, Clarke W, Breaud A, Richardson P, Piwowar-Manning E, Hart S, Hamilton EL, Hoa NTK, Liulchuk M, Anandari L, Ha TV, Dumchev K, et al. HIV drug resistance in persons who inject drugs enrolled in an HIV prevention trial in Indonesia, Ukraine, and Vietnam: HPTN 074. Plos One. 14: e0223829. PMID 31600343 DOI: 10.1371/Journal.Pone.0223829  0.799
2019 Fogel JM, Zhang Y, Palumbo PJ, Guo X, Clarke W, Breaud A, Richardson P, Piwowar-Manning E, Hamilton EL, Ha TV, Dumchev K, Djoerban Z, Hoffman I, Hanscom B, Miller WC, et al. Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject Drugs. Aids and Behavior. PMID 30600453 DOI: 10.1007/S10461-018-2379-8  0.809
2018 Sivay MV, Fogel JM, Wang J, Zhang Y, Piwowar-Manning E, Clarke W, Breaud A, Blankson J, Hamilton EL, Kahn K, Selin A, Gomez-Olive FX, MacPhail C, Hughes JP, Pettifor A, et al. Natural control of HIV infection in young women in South Africa: HPTN 068. Hiv Clinical Trials. 1-7. PMID 30522410 DOI: 10.1080/15284336.2018.1531534  0.786
2018 Fogel JM, Sandfort T, Zhang Y, Guo X, Clarke W, Breaud A, Cummings V, Hamilton EL, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Eshleman SH. Accuracy of Self-Reported HIV Status Among African Men and Transgender Women Who Have Sex with Men Who were Screened for Participation in a Research Study: HPTN 075. Aids and Behavior. PMID 30051192 DOI: 10.1007/S10461-018-2231-1  0.786
2018 Zhang Y, Sivay MV, Hudelson SE, Clarke W, Breaud A, Wang J, Piwowar-Manning E, Agyei Y, Fogel JM, Hamilton EL, Selin A, MacPhail C, Kahn K, Gomez-Olive FX, Hughes JP, et al. Antiretroviral Drug Use and HIV Drug Resistance Among Young Women in Rural South Africa: HPTN 068. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29985265 DOI: 10.1097/Qai.0000000000001793  0.769
2018 Zhang Y, Fogel JM, Guo X, Clarke W, Breaud A, Cummings V, Hamilton EL, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Sandfort T, Eshleman SH. Antiretroviral drug use and HIV drug resistance among men who have sex with men and transgender women in sub-Saharan Africa: HPTN 075 study. Aids (London, England). PMID 29794492 DOI: 10.1097/Qad.0000000000001839  0.775
2018 Eshleman SH, Piwowar-Manning E, Sivay MV, Debevec B, Veater S, McKinstry L, Bekker LG, Mannheimer S, Grant RM, Chesney MA, Coates TJ, Koblin BA, Fogel JM. Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 99: 67-70. PMID 29346085 DOI: 10.1016/J.Jcv.2018.01.003  0.798
2017 Palumbo PJ, Fogel JM, Hudelson SE, Wilson EA, Hart S, Hovind L, Piwowar-Manning E, Wallis C, Papathanasopoulos MA, Morgado MG, Saravanan S, Tripathy S, Eron JJ, Gallant JE, Mph, et al. Hiv Drug Resistance in Adults Receiving Early Versus Delayed Antiretroviral Therapy: Hptn 052. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29293156 DOI: 10.1097/QAI.0000000000001623  0.674
2017 Palumbo PJ, Wilson EA, Piwowar-Manning E, McCauley M, Gamble T, Kumwenda N, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim JG, Hosseinipour MC, Melo MG, Godbole SV, Pilotto JH, Grinsztejn B, ... ... Fogel JM, et al. Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052. Plos One. 12: e0177281. PMID 28481902 DOI: 10.1371/Journal.Pone.0177281  0.813
2017 Fogel JM, Piwowar-Manning E, Debevec B, Walsky T, Schlusser K, Laeyendecker O, Wilson EA, McCauley M, Gamble T, Tegha G, Biomed M, Soko D, Kumwenda J, Hosseinipour MC, Chen YQ, et al. Impact of early antiretroviral therapy on the performance of HIV rapid tests and HIV incidence assays. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28471839 DOI: 10.1097/Qai.0000000000001421  0.8
2017 Eshleman SH, Wilson EA, Zhang XC, Ou SS, Piwowar-Manning E, Eron JJ, McCauley M, Gamble T, Gallant JE, Hosseinipour MC, Kumarasamy N, Hakim JG, Kalonga B, Pilotto JH, Grinsztejn B, ... ... Fogel JM, et al. Virologic outcomes in early antiretroviral treatment: HPTN 052. Hiv Clinical Trials. 1-10. PMID 28385131 DOI: 10.1080/15284336.2017.1311056  0.781
2016 Fogel JM, Clarke W, Kulich M, Piwowar-Manning E, Breaud A, Olson MT, Marzinke MA, Laeyendecker O, Fiamma A, Donnell D, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, et al. Antiretroviral drug use in a cross-sectional population survey in Africa: NIMH Project Accept (HPTN 043). Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27828875 DOI: 10.1097/Qai.0000000000001229  0.746
2016 Eshleman SH, Hudelson SE, Redd AD, Swanstrom R, Ou SS, Zhang XC, Ping LH, Piwowar-Manning E, Porcella SF, Sievers MF, Martens CA, Bruno D, Dukhovlinova E, McCauley M, Gamble T, ... Fogel JM, et al. Treatment as Prevention: Characterization of partner infections in the HIV Prevention Trials Network 052 trial. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27532476 DOI: 10.1097/Qai.0000000000001158  0.771
2016 Fogel JM, Hudelson SE, Ou SS, Hart S, Wallis C, Morgado MG, Saravanan S, Tripathy S, Hovind L, Piwowar-Manning E, Sabin D, McCauley M, Gamble T, Zhang XC, Eron JJ, et al. HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV Prevention Trials Network 052 trial. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26859828 DOI: 10.1097/Qai.0000000000000951  0.763
2015 Redd AD, Wendel SK, Longosz AF, Fogel JM, Dadabhai S, Kumwenda N, Sun J, Walker MP, Bruno D, Martens C, Eshleman SH, Porcella SF, Quinn TC, Taha TE. Evaluation of postpartum HIV superinfection and mother-to-child transmission. Aids (London, England). 29: 1567-73. PMID 26244396 DOI: 10.1097/Qad.0000000000000740  0.802
2015 Hall G, Li K, Wilton L, Wheeler D, Fogel J, Wang L, Koblin B. A Comparison of Referred Sexual Partners to Their Community Recruited Counterparts in The BROTHERS Project (HPTN 061). Aids and Behavior. PMID 25874753 DOI: 10.1007/S10461-015-1005-2  0.445
2015 Chen I, Connor MB, Clarke W, Marzinke MA, Cummings V, Breaud A, Fogel JM, Laeyendecker O, Fields SD, Donnell D, Griffith S, Scott HM, Shoptaw S, Del Rio C, Magnus M, et al. Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 446-52. PMID 25861015 DOI: 10.1097/Qai.0000000000000633  0.817
2015 Fogel JM, Piwowar-Manning E, Donohue K, Cummings V, Marzinke MA, Clarke W, Breaud A, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, et al. Determination of HIV Status in African Adults With Discordant HIV Rapid Tests. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 430-8. PMID 25835607 DOI: 10.1097/Qai.0000000000000610  0.807
2015 Piwowar-Manning E, Fogel JM, Richardson P, Wolf S, Clarke W, Marzinke MA, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH. Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 62: 75-9. PMID 25542477 DOI: 10.1016/J.Jcv.2014.11.023  0.819
2014 Chen I, Cummings V, Fogel JM, Marzinke MA, Clarke W, Connor MB, Griffith S, Buchbinder S, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, et al. Low-level Viremia early in HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 405-8. PMID 25140905 DOI: 10.1097/Qai.0000000000000298  0.86
2014 Piwowar-Manning E, Fogel JM, Laeyendecker O, Wolf S, Cummings V, Marzinke MA, Clarke W, Breaud A, Wendel S, Wang L, Swanson P, Hackett J, Mannheimer S, Del Rio C, Kuo I, et al. Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screening. Hiv Clinical Trials. 15: 62-8. PMID 24710920 DOI: 10.1310/Hct1502-62  0.821
2014 Marzinke MA, Clarke W, Wang L, Cummings V, Liu TY, Piwowar-Manning E, Breaud A, Griffith S, Buchbinder S, Shoptaw S, del Rio C, Magnus M, Mannheimer S, Fields SD, Mayer KH, ... ... Fogel JM, et al. Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 117-20. PMID 24092804 DOI: 10.1093/Cid/Cit672  0.85
2013 Fogel JM, Wang L, Parsons TL, Ou SS, Piwowar-Manning E, Chen Y, Mudhune VO, Hosseinipour MC, Kumwenda J, Hakim JG, Chariyalertsak S, Panchia R, Sanne I, Kumarasamy N, Grinsztejn B, et al. Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052). The Journal of Infectious Diseases. 208: 1624-8. PMID 23908493 DOI: 10.1093/Infdis/Jit390  0.696
2013 Fogel JM, Mwatha A, Richardson P, Brown ER, Chipato T, Alexandre M, Moodley D, Elbireer A, Mirochnick M, George K, Mofenson LM, Zwerski S, Coovadia HM, Eshleman SH. Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants. The Pediatric Infectious Disease Journal. 32: e164-9. PMID 23249916 DOI: 10.1097/Inf.0B013E31827F44Ee  0.753
2012 James MM, Wang L, Donnell D, Cousins MM, Barlow-Mosha L, Fogel JM, Towler WI, Agwu AL, Bagenda D, Mubiru M, Musoke P, Eshleman SH. Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children. The Pediatric Infectious Disease Journal. 31: e222-8. PMID 22785048 DOI: 10.1097/Inf.0B013E3182678C3F  0.813
2012 Fogel JM, Taha TE, Sun J, Hoover DR, Parsons TL, Kumwenda JJ, Mofenson LM, Fowler MG, Hendrix CW, Kumwenda NI, Eshleman SH, Mirochnick M. Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants. Journal of Acquired Immune Deficiency Syndromes (1999). 60: 462-5. PMID 22614899 DOI: 10.1097/Qai.0B013E31825Ddcfa  0.49
2011 James MM, Wang L, Musoke P, Donnell D, Fogel J, Towler WI, Khaki L, Nakabiito C, Jackson JB, Eshleman SH. Association of HIV diversity and survival in HIV-infected Ugandan infants. Plos One. 6: e18642. PMID 21533179 DOI: 10.1371/Journal.Pone.0018642  0.839
2011 Fogel J, Hoover DR, Sun J, Mofenson LM, Fowler MG, Taylor AW, Kumwenda N, Taha TE, Eshleman SH. Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis. Aids (London, England). 25: 911-7. PMID 21487249 DOI: 10.1097/Qad.0B013E328344Fedc  0.751
2011 Fogel J, Li Q, Taha TE, Hoover DR, Kumwenda NI, Mofenson LM, Kumwenda JJ, Fowler MG, Thigpen MC, Eshleman SH. Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 1069-76. PMID 21460326 DOI: 10.1093/Cid/Cir008  0.726
Show low-probability matches.